<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Public Meeting on Patient-Focused Drug Development for Neuropathic Pain Associated With Peripheral Neuropathy</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Public Meeting on Patient-Focused Drug Development for Neuropathic Pain Associated With Peripheral Neuropathy</h1>
    <p class="timestamp">Published: 2016-04-18 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing a public meeting and an opportunity for public comment on Patient- Focused Drug Development for neuropathic pain associated with peripheral neuropathies. Patient-Focused Drug Development is part of FDA's performance commitments made as part of the fifth authorization of the Prescription Drug User Fee Act (PDUFA V). The public meeting is intended to allow FDA to obtain patient perspectives on the impact of neuropathic pain associated ...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2016-08881</p>
    <p><strong>Publication Date:</strong> 2016-04-18</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2016/04/18/2016-08881/public-meeting-on-patient-focused-drug-development-for-neuropathic-pain-associated-with-peripheral">https://www.federalregister.gov/documents/2016/04/18/2016-08881/public-meeting-on-patient-focused-drug-development-for-neuropathic-pain-associated-with-peripheral</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2016-08881</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
